Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Population-based survey of antimycobacterial drug use among patients with non-tuberculosis mycobacterial pulmonary disease

Kiyohiko Izumi, Kozo Morimoto, Kazuhiro Uchimura, Manabu Ato, Naoki Hasegawa, Satoshi Mitarai
ERJ Open Research 2020 6: 00097-2019; DOI: 10.1183/23120541.00097-2019
Kiyohiko Izumi
1The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan
6These authors contributed equally
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kizumi95@gmail.com
Kozo Morimoto
1The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan
2Fukujuji Hospital, Japan Anti-Tuberculosis Association, Tokyo, Japan
6These authors contributed equally
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kazuhiro Uchimura
1The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manabu Ato
3Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Manabu Ato
Naoki Hasegawa
4Keio University School of Medicine, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Satoshi Mitarai
1The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan
5Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Tables

  • TABLE 1

    The demographic and clinical factors associated with nonstandard treatment

    VariableTotal patients with standard and nonstandard treatment (N=15 431)Patients with nonstandard treatment (N=8460)Univariate analysisMultivariate analysis
    OR (95% CI)p-valueaOR (95% CI)p-value
    Sex
     Males41972359 (56.2%)Ref.Ref.
     Females11 2346101 (54.3%)0.93 (0.86–0.99)0.0350.98 (0.91–1.06)0.640
    Age years
     40–49520209 (40.2%)Ref.Ref.
     50–591798816 (45.4%)1.24 (1.01–1.51)0.0361.23 (1.01–1.5)0.044
     60–6944442188 (49.2%)1.44 (1.2–1.74)<0.0011.42 (1.18–1.71)<0.001
     70–7955683162 (56.8%)1.96 (1.63–2.35)<0.0011.92 (1.6–2.31)<0.001
     ≥8031012085 (67.2%)3.05 (2.52–3.7)<0.0013.01 (2.49–3.65)<0.001
    Comorbidity
     Rheumatoid arthritis
      No13 9987591 (54.2%)Ref.Ref.
      Yes1433869 (60.6%)1.30 (1.16–1.45)<0.0011.36 (1.21–1.53)<0.001
     Bronchiectasis
      No11 6646380 (54.7%)Ref.Ref.
      Yes37672080 (55.2%)1.02 (0.95–1.1)0.5791.02 (0.95–1.1)0.618
     COPD
      No14 3507783 (54.2%)Ref.Ref.
      Yes1081677 (62.6%)1.41 (1.24–1.61)<0.0011.31 (1.14–1.49)<0.001
     Sequelae of pulmonary TB
      No14 6287988 (54.6%)Ref.Ref.
      Yes803472 (58.8%)1.19 (1.03–1.37)0.0211.02 (0.88–1.18)0.828
     Interstitial pneumonia
      No14 0387655 (54.5%)Ref.Ref.
      Yes1393805 (57.8%)1.14 (1.02–1.28)0.0201.02 (0.91–1.15)0.732

    Patients who did not receive treatment were excluded from the regression analysis. International Classification of Diseases 10 codes for aspergillosis (B487, B449 and B441), rheumatoid arthritis (M0510, M0530, M0590, M0600, M0690, M0691, M0692, M0693, M0694, M0695, M0696, M0697, M0698 and M0800), bronchiectasis (J47, A162 and Q334), COPD (J449), sequelae of pulmonary tuberculosis (TB) (B909), lung cancer (C340, C341, C342, C343, C349, C780, C795 and Z122), interstitial pneumonia (J704, J841, J849, M0510, M330, M321, M332 and M351) and diabetes mellitus (E10 and E11). To ensure the specificity of comorbidities, a comorbidity was identified when at least five associated claims were made. aOR: adjusted odds ratio; Ref.: reference. p<0.05 was considered statistically significant.

    PreviousNext
    Back to top
    Vol 6 Issue 1 Table of Contents
    ERJ Open Research: 6 (1)
    • Table of Contents
    • Index by author
    Email

    Thank you for your interest in spreading the word on European Respiratory Society .

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Population-based survey of antimycobacterial drug use among patients with non-tuberculosis mycobacterial pulmonary disease
    (Your Name) has sent you a message from European Respiratory Society
    (Your Name) thought you would like to see the European Respiratory Society web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Print
    Citation Tools
    Population-based survey of antimycobacterial drug use among patients with non-tuberculosis mycobacterial pulmonary disease
    Kiyohiko Izumi, Kozo Morimoto, Kazuhiro Uchimura, Manabu Ato, Naoki Hasegawa, Satoshi Mitarai
    ERJ Open Research Jan 2020, 6 (1) 00097-2019; DOI: 10.1183/23120541.00097-2019

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Share
    Population-based survey of antimycobacterial drug use among patients with non-tuberculosis mycobacterial pulmonary disease
    Kiyohiko Izumi, Kozo Morimoto, Kazuhiro Uchimura, Manabu Ato, Naoki Hasegawa, Satoshi Mitarai
    ERJ Open Research Jan 2020, 6 (1) 00097-2019; DOI: 10.1183/23120541.00097-2019
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    Full Text (PDF)

    Jump To

    • Article
      • Abstract
      • Acknowledgments
      • Footnotes
      • References
    • Figures & Data
    • Info & Metrics
    • PDF

    Subjects

    • Respiratory infections and tuberculosis
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    More in this TOC Section

    • rs2070600 SNP regulates AGER splicing and sputum sRAGE
    • Procoagulant microparticles and COVID-19
    • Cancer referral and interventional pulmonology during COVID-19
    Show more Original research letters

    Related Articles

    Navigate

    • Home
    • Current issue
    • Archive

    About ERJ Open Research

    • Editorial board
    • Journal information
    • Press
    • Permissions and reprints
    • Advertising

    The European Respiratory Society

    • Society home
    • myERS
    • Privacy policy
    • Accessibility

    ERS publications

    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS books online
    • ERS Bookshop

    Help

    • Feedback

    For authors

    • Instructions for authors
    • Publication ethics and malpractice
    • Submit a manuscript

    For readers

    • Alerts
    • Subjects
    • RSS

    Subscriptions

    • Accessing the ERS publications

    Contact us

    European Respiratory Society
    442 Glossop Road
    Sheffield S10 2PX
    United Kingdom
    Tel: +44 114 2672860
    Email: journals@ersnet.org

    ISSN

    Online ISSN: 2312-0541

    Copyright © 2023 by the European Respiratory Society